According to OpGen
's latest financial reports the company has a price-to-book ratio of 2.24.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.57 | 57.2% |
2022-12-31 | 0.9995 | -11.41% |
2021-12-31 | 1.13 | -47.89% |
2020-12-31 | 2.16 | 47.35% |
2019-12-31 | 1.47 | -56.75% |
2018-12-31 | 3.40 | -54.86% |
2017-12-31 | 7.52 | -4.57% |
2016-12-31 | 7.88 | 147.75% |
2015-12-31 | 3.18 | |
2014-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Lexicon Pharmaceuticals
LXRX | 2.79 | 24.26% | ๐บ๐ธ USA |
Enzo Biochem ENZ | 0.7636 | -65.98% | ๐บ๐ธ USA |